- 誘導(dǎo)多能干細(xì)胞共 8505 條
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：RAS 相關(guān)自身免疫性白細(xì)胞增殖性疾病 (RALD)。細(xì)胞株-BioVector細(xì)胞庫HPS1798
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：暴發(fā)性肝炎。細(xì)胞株-BioVector細(xì)胞庫HPS1813
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：暴發(fā)性肝炎。細(xì)胞株-BioVector細(xì)胞庫HPS1813
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：腓骨肌萎縮癥。細(xì)胞株-BioVector細(xì)胞庫HPS1814
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：腓骨肌萎縮癥。細(xì)胞株-BioVector細(xì)胞庫HPS1814
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：腓骨肌萎縮癥。細(xì)胞株-BioVector細(xì)胞庫HPS1815
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：腓骨肌萎縮癥。細(xì)胞株-BioVector細(xì)胞庫HPS1815
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：遺傳性肌張力障礙。細(xì)胞株-BioVector細(xì)胞庫HPS1817
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：遺傳性肌張力障礙。細(xì)胞株-BioVector細(xì)胞庫HPS1817
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1818
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1818
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1819
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1819
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1820
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1820
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1821
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1821
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1822
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1822
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1823
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1823
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1824
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1824
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1825
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1825
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1827
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1827
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1828
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1828
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1829
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1829
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1830
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1830
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1831
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。分析因果遺傳變化。細(xì)胞株-BioVector細(xì)胞庫HPS1831
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1832
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1832
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1833
Cell Line NTCC?來自患者的疾病特異性 iPS 細(xì)胞系：肌萎縮側(cè)索硬化癥 (ALS)。細(xì)胞株-BioVector細(xì)胞庫HPS1833
- 快速發(fā)布求購信息
